Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Environmental Science and Pollution Research International|November 16, 2022
Using an innovative umbrella-shape membrane module to improve MBR for PN-ANAMMOX processHongying Yun, Tao Wang, Hao Meng, et al.The Journal of Organic Chemistry|August 13, 2005
Stereoselective synthesis of constrained azacyclic hydroxyethylene isosteres as aspartic protease inhibitors: dipolar cycloaddition and related methodologies toward branched pyrrolidine and pyrrolidinone carboxylic acidsStephen Hanessian, Hongying Yun, Yihua Hou, et al.Ultrasonics Sonochemistry|January 31, 2021
Enhancement of Anammox performances in an ABR at normal temperature by the low-intensity ultrasonic irradiationLuzi Yuan, Tao Wang, Fanghua Xing, et al.Chemosphere|March 24, 2024
Anammox process in anaerobic baffled biofilm reactors with columnar packings: Characteristics of flow field and microbial communityXian Wang, Tao Wang, Hao Meng, et al.European Journal of Medicinal Chemistry|August 4, 2017
Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitorsSong Feng, Chao Li, Dongdong Chen, et al.ACS Medicinal Chemistry Letters|June 22, 2016
Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion InhibitorsXiufang Zheng, Lisha Wang, Baoxia Wang, et al.ACS Medicinal Chemistry Letters|May 6, 2015
Discovery of imidazopyridine derivatives as highly potent respiratory syncytial virus fusion inhibitorsSong Feng, Di Hong, Baoxia Wang, et al.Antimicrobial Agents and Chemotherapy|March 30, 2021
Discovery of a Novel Respiratory Syncytial Virus Replication InhibitorLi Wang, Qihui Zhu, Kunlun Xiang, et al.Journal of Medicinal Chemistry|October 20, 2018
Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion InhibitorsXiufang Zheng, Chungen Liang, Lisha Wang, et al.Medchemcomm|July 16, 2019
Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitorsXiufang Zheng, Chungen Liang, Lisha Wang, et al.Pageof 2